Phase Scientific raises Series A funding
Biotechnology firm Phase Scientific has completed a USD 34 million Series A funding round led by a private equity fund managed by Value Partners Group, with support from undisclosed new and existing investors. The funds will be used to accelerate R&D and commercialization of the company’s urine-based diagnostic technology, aimed at making early disease detection more accessible through at-home testing.